Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41 (2023)
- Authors:
- Autor USP: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM
- Unidade: FM
- DOI: 10.1182/bloodadvances.2023010045
- Subjects: DOENÇAS GENÉTICAS; LEUCÓCITOS; FATORES DE RISCO; MUTAÇÃO GENÉTICA; PREVALÊNCIA
- Agências de fomento:
- RUNX1 Research Program
- Leukemia Foundation of Australia
- National Health and Medical Research Council of Australia
- State Government of South Australia through the Department of Health
- Damon Runyon Cancer Research Foundation Physician Scientist Training Award
- Edward P. Evans Foundation Young Investigator Award
- Cancer Research Foundation
- National Institutes of Health (NIH) K12 Paul Calabresi award
- fellowship from The Hospital Research Foundation
- Associazione Italiana per la Ricerca sul Cancro
- Maddie Riewoldt's Vision
- Cancer Research Foundation
- Division of Intramural Research, National Human Genome Research Institute, NIH
- European Hematology Association
- Federal Ministry of Education and Research (BMBF) MyPred
- European Union
- Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
- [01GM1911B]
- [739593]
- [ED-18-1-2019]
- Language: Inglês
- Imprenta:
- Source:
- Título: Blood advances
- ISSN: 2473-9529
- Volume/Número/Paginação/Ano: v. 7, n. 20, p. 6092-6107, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HOMAN, Claire C et al. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41. Blood advances, v. 7, n. 20, p. 6092-6107, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57340. Acesso em: 05 mar. 2026. -
APA
Homan, C. C., Drazer, M. W., Yu, K., Lawrence, D. M., Feng, J., Arriola-Martinez, L., et al. (2023). Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41. Blood advances, 7( 20), 6092-6107. doi:10.1182/bloodadvances.2023010045 -
NLM
Homan CC, Drazer MW, Yu K, Lawrence DM, Feng J, Arriola-Martinez L, Pozsgai MJ, Mcneely KE, Ha T, Velloso EDRP. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41 [Internet]. Blood advances. 2023 ; 7( 20): 6092-6107.[citado 2026 mar. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57340 -
Vancouver
Homan CC, Drazer MW, Yu K, Lawrence DM, Feng J, Arriola-Martinez L, Pozsgai MJ, Mcneely KE, Ha T, Velloso EDRP. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41 [Internet]. Blood advances. 2023 ; 7( 20): 6092-6107.[citado 2026 mar. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57340 - Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations. [Carta]
- Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome
- Aids: manifestações hematológicas e oncólogicas relacionadas
- TCRAD rearrangement in B-cell precursor leukemia: an unexpected finding
- Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients
- Part 3: Myelodysplastic syndromes—treatment of low-risk patients without the 5q deletion
- Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates
- Tratamento onco-hematólogico no idoso - indicações e limitações
- Contribuicao ao estudo clinico e hematologico das sindromes mielodisplasicas
- Part 4: Myelodysplastic syndromes—Treatment of low-risk patients with the 5q deletion
Informações sobre o DOI: 10.1182/bloodadvances.2023010045 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
